Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Biomaster

Biomaster
2002 FOUNDED
M&A STATUS
M&A LATEST DEAL TYPE
2 FINANCING ROUNDS
Description

Developer of regenerative medicines. The company's regenerative medicines include adipose derived stem cell, enabling the medical industry to increases the soft tissue of the body for fighting facial degenerative diseases.

Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Corporate Backed or Acquired
Primary Industry
Drug Discovery
Parent Company
Primary Office
  • Yokohama Excellent III 2nd Floor
  • 35th Minami-mer 3-chome Minami-ku
  • Yokohama-shi, 231-0006
  • Japan

+81 000-000-0000

Biomaster Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Biomaster‘s full profile, request access.

Request full access to PitchBook

Biomaster Former Investors

Investor Name Investor Type Holding Participating Rounds Investor Since Board Seat Contact Info

This information is reserved for PitchBook Platform users. To explore Biomaster‘s full profile, request access.

Request full access to PitchBook

Biomaster Executive Team (1)

Name Title Board
Seat
Contact
Info
Satoshi Nakatani President